Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.

Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM.

J Pathol. 1997 Jul;182(3):318-24.

PMID:
9349235
2.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
3.

The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.

Curtis NJ, Primrose JN, Thomas GJ, Mirnezami AH, Ottensmeier CH.

Eur J Surg Oncol. 2012 Oct;38(10):889-96. doi: 10.1016/j.ejso.2012.05.011. Epub 2012 Jun 19. Review.

PMID:
22721580
4.

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

Dunn GP, Dunn IF, Curry WT.

Cancer Immun. 2007 Aug 13;7:12. Review.

5.

Clinical practice. Surveillance strategies after curative treatment of colorectal cancer.

Pfister DG, Benson AB 3rd, Somerfield MR.

N Engl J Med. 2004 Jun 3;350(23):2375-82. Review. No abstract available.

PMID:
15175439
6.

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW.

Br J Cancer. 2011 Jun 28;105(1):93-103. doi: 10.1038/bjc.2011.189. Epub 2011 May 31. Review.

7.

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer.

Ahn SG, Jeong J, Hong S, Jung WH.

J Pathol Transl Med. 2015 Sep;49(5):355-63. doi: 10.4132/jptm.2015.07.29. Epub 2015 Aug 17. Review.

8.

Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.

Donnem T, Kilvaer TK, Andersen S, Richardsen E, Paulsen EE, Hald SM, Al-Saad S, Brustugun OT, Helland A, Lund-Iversen M, Solberg S, Gronberg BH, Wahl SG, Helgeland L, Fløtten O, Pohl M, Al-Shibli K, Sandanger TM, Pezzella F, Busund LT, Bremnes RM.

Ann Oncol. 2016 Feb;27(2):225-32. doi: 10.1093/annonc/mdv560. Epub 2015 Nov 16. Review.

PMID:
26578726
9.

Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer.

Ingold Heppner B, Loibl S, Denkert C.

Breast Care (Basel). 2016 Apr;11(2):96-100. doi: 10.1159/000444357. Epub 2016 Apr 26. Review.

PMID:
27239170
Items per page

Supplemental Content

Write to the Help Desk